Provided by Tiger Fintech (Singapore) Pte. Ltd.

Addex Therapeutics Ltd

7.54
+0.44006.20%
Post-market: 7.53-0.0100-0.13%16:00 EDT
Volume:5.35K
Turnover:40.34K
Market Cap:8.06M
PE:1.01
High:7.89
Open:7.41
Low:6.90
Close:7.10
Loading ...
Aug 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Apr 18, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Dec 09, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 30, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 01, 2023

Correspondence

Form CORRESP - Correspondence
Jun 01, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
May 12, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
May 03, 2023

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Apr 10, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 05, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 31, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 30, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]